Target intelligence / Profile preview

Histone H4 clustered 7 (H4C7)

Target
H4C7
Molecular classification
Histone, Chromatin protein, Structural chromatin component
01

Overview

Histone H4 clustered 7 (H4C7) encodes a replication-dependent histone protein that is a core component of the nucleosome, the primary packaging unit of eukaryotic chromatin. Two molecules each of the four core histones (H2A, H2B, H3, H4) form an octamer, around which DNA is wound. This packaging limits DNA accessibility to the cellular machinery involved in processes such as transcription, replication, repair, and chromosomal stability. H4C7 is intronless, encoded in a large histone gene cluster on chromosome 6, and its transcripts lack polyA tails, instead terminating with a palindromic sequence. Alterations in histone composition, including H4C7, may contribute to diseases such as cancer, with some evidence suggesting a role for H4G (H4C7) in regulating ribosomal DNA transcription in breast cancer[1][2][5][6]. Histones such as H4C7 are not typical therapeutic drug targets or disease biomarkers; rather, they are central chromatin components whose perturbation can have widespread effects on genome function.

Other names
Histone H4-like protein type GH4C7H4/LH4FLHIST1H4GH4/lhistone H4-like protein type GH4 histone family, member Lhistone 1, H4ghistone cluster 1 H4 family member ghistone cluster 1, H4g
02

Mechanism of action

not applicable (no direct-acting drugs or mechanism of pharmacological intervention reported)

03

Biological functions

Chromatin organizationDNA packagingRegulation of transcriptionDNA repairDNA replicationChromosomal stability
04

Disease associations

Cancer (notably implicated in breast cancer due to regulation of ribosomal DNA transcription)Other (possible broad chromatin/disease relevance through epigenetic regulation)
05

Safety considerations

none established (as there are no drugs targeting H4C7, and as a core histone, targeting may pose major safety challenges due to essential roles in chromatin structure and cell viability)
06

Interacting drugs

none known (no specific drugs are reported to directly target H4C7 as a therapeutic intervention)
07

Biomarkers

none established (H4C7 is not currently used as a biomarker for patient selection or efficacy monitoring in clinical medicine)

Beyond the preview

Go deeper on Histone H4 clustered 7 (H4C7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Histone H4 clustered 7 (H4C7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call